DE69829417D1 - Polypeptides and nucleic acid encoding them - Google Patents

Polypeptides and nucleic acid encoding them

Info

Publication number
DE69829417D1
DE69829417D1 DE69829417T DE69829417T DE69829417D1 DE 69829417 D1 DE69829417 D1 DE 69829417D1 DE 69829417 T DE69829417 T DE 69829417T DE 69829417 T DE69829417 T DE 69829417T DE 69829417 D1 DE69829417 D1 DE 69829417D1
Authority
DE
Germany
Prior art keywords
polypeptides
nucleic acid
present
acid encoding
those
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69829417T
Other languages
German (de)
Other versions
DE69829417T2 (en
Inventor
William I Wood
Austin L Gurney
Audrey Goddard
Diane Pennica
Jian Chen
Jean Yuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DE69829417D1 publication Critical patent/DE69829417D1/en
Publication of DE69829417T2 publication Critical patent/DE69829417T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. <IMAGE>
DE69829417T 1997-09-18 1998-09-16 Polypeptides and nucleic acid encoding them Expired - Lifetime DE69829417T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5926397P 1997-09-18 1997-09-18
US59263 1998-04-14

Publications (2)

Publication Number Publication Date
DE69829417D1 true DE69829417D1 (en) 2005-04-21
DE69829417T2 DE69829417T2 (en) 2006-04-13

Family

ID=34374780

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69829417T Expired - Lifetime DE69829417T2 (en) 1997-09-18 1998-09-16 Polypeptides and nucleic acid encoding them

Country Status (7)

Country Link
US (1) US20070088151A1 (en)
EP (1) EP1205550B1 (en)
AT (1) ATE291085T1 (en)
DE (1) DE69829417T2 (en)
DK (1) DK1205550T3 (en)
ES (1) ES2240310T3 (en)
PT (1) PT1205550E (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824549A (en) * 1990-10-09 1998-10-20 Chiron Corporation Transformed human T cell
AU5816799A (en) * 1998-09-10 2000-04-03 Genentech Inc. Compositions and methods for the treatment of tumor

Also Published As

Publication number Publication date
DE69829417T2 (en) 2006-04-13
PT1205550E (en) 2005-07-29
DK1205550T3 (en) 2005-07-18
EP1205550A1 (en) 2002-05-15
ATE291085T1 (en) 2005-04-15
ES2240310T3 (en) 2005-10-16
EP1205550B1 (en) 2005-03-16
US20070088151A1 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
ATE447583T1 (en) POLYPEPTIDES AND NUCLEIC ACIDS CODING THEREFOR
ATE409228T1 (en) SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACID CODING THEREFOR
PT1386931E (en) HOMOLOGO DE NEUROTRIMINA HUMANA
ATE310810T1 (en) POLYPEPTIDE AND NUCEINIC ACID CODING THEREOF
KR100515858B1 (en) PRO617 Polypeptides
DE69829417D1 (en) Polypeptides and nucleic acid encoding them
KR100515855B1 (en) PRO351 Polypeptides
KR100515856B1 (en) PRO618 Polypeptides
DE69827532D1 (en) Polypeptides and nucleic acid encoding them
DE69829230D1 (en) Polypeptide and nucleic acid encoded therefor
KR100515857B1 (en) PRO792 Polypeptides
ATE402954T1 (en) HUMAN A33 ANTIGEN-LIKE PROTEIN AND NUCLEIC ACID ENCODING THEREOF
DK1191101T3 (en) PRO241 polypeptides and nucleic acid encoding them
DK1300417T3 (en) Therefore, secreted and transmembrane polypeptide and nucleic acid encoding
DE69926415D1 (en) Secreted polypeptides and nucleic acids coding for them
DE69930422D1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding them
ATE404585T1 (en) HUMAN SYNAPTOGYRINE-LIKE PROTEIN AND NUCLEIC ACID ENCODING THEREOF
ATE405590T1 (en) HUMAN HCAR-LIKE PROTEIN AND NUCLEIC ACID ENCODING THEREOF
DE60043242D1 (en) Secreted and transmembrane polypeptides and nucleic acid coding therefor
ATE396201T1 (en) SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACID CODING THEREFOR
ATE363537T1 (en) SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACID CODING THEREFOR

Legal Events

Date Code Title Description
8364 No opposition during term of opposition